ALPHA(1)-ANTITRYPSIN THERAPY IN A CASE OF THROMBOTIC THROMBOCYTOPENICPURPURA

Citation
M. Galbusera et al., ALPHA(1)-ANTITRYPSIN THERAPY IN A CASE OF THROMBOTIC THROMBOCYTOPENICPURPURA, Lancet, 345(8944), 1995, pp. 224-225
Citations number
9
Categorie Soggetti
Medicine, General & Internal
Journal title
LancetACNP
ISSN journal
01406736
Volume
345
Issue
8944
Year of publication
1995
Pages
224 - 225
Database
ISI
SICI code
0140-6736(1995)345:8944<224:ATIACO>2.0.ZU;2-G
Abstract
In thrombotic thrombocytopenic purpura (TTP), activated leucocytes rel ease elastase which large von Willebrand factor (vWF) endothelium. We investigated the effect of an inhibitor of leucocyte elastase (alpha(1 )-antitrypsin) on circulating vWF and platelet count in a patient with chronic relapsing TTP. alpha(1)-antitrypsin consistently normalised v WF multimeric composition but failed to Increase platelet count and in duce remission. Plasma cryosupernatant, which never normalised VWF, al ways induced laboratory and clinical remission within 96 hours. In chr onic relapsing TTP, unusually large VWF multimers are not the main cau se of intravascular platelet aggregation.